Cytodyn Inc (CYDY)

[Hookmeistr]

C-20 couldn't agree more. In the last trial, we saw 82% at the end of the 2nd week, day 14. With that, there was what I would call 'stacking' of the drug. In other words, there were residuals from the first dose still present when the 2nd dose was administered, thereby stacking the drug and providing a higher survival rate.

The fact that we now will be able to inject a 3rd and 4th dose will allow for more stacking. By the 3rd dose, most of the 1st dose will most likely be out of the system. However, the effects will then be 'stacked'. The immune system will be in a better state to be able to properly function because the cytokine storm will be less of an issue as it's reduced by leronlimab.

By the 4th dose, there is even more stacking of the positive effects because, once again, the immune system is that much more effective in that it's more able to do its job at fighting and killing the virus since it's not fighting against the cytokine storm.

So, you now have 4 doses instead of two, creating continued stacking of the drug (overlapping) and stacking of the effects by continual defeat of the cytokine storm while the body is then allowed to naturally fight off the virus for the win.

I'm no medical expert but that's my layman's understanding and belief as to how the drug works and will be more effective in this new Brazilian trial.

Go LERONLIMAB FOR THE WIN!!